BusinessFederman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Bellicum Pharmaceuticals, Inc.By Nasdaq OMXFeb 12, 2018, 8:17 PM UTC
BusinessBellicum Reports Clinical Results of BPX-501 in Pediatric Leukemias at the 22nd Congress of the European Hematology AssociationBy Nasdaq OMXJun 23, 2017, 11:00 AM UTC
BusinessBellicum Announces Clinical Data on BPX-501 at Presidential Symposium of the 22nd Congress of the European Hematology AssociationBy Nasdaq OMXJun 23, 2017, 11:00 AM UTC
